Brilliant Board Review & CME

著者: Brilliant Board Review & CME
  • サマリー

  • Latest Updates in Internal Medicine for General Internal Medicine, Medicine Sub specialists, Hospitalists, Family Medicine, Nurse Practitioners and Physician Assistants.

    © 2025 Brilliant Board Review & CME
    続きを読む 一部表示

あらすじ・解説

Latest Updates in Internal Medicine for General Internal Medicine, Medicine Sub specialists, Hospitalists, Family Medicine, Nurse Practitioners and Physician Assistants.

© 2025 Brilliant Board Review & CME
エピソード
  • Unlocking Relief: The Power of New Migraine Treatments
    2025/02/28

    Send us a text

    We share vital insights into new migraine treatments aimed at individuals who have struggled with traditional therapies. The episode delves into the specifics of episodic migraines and innovative solutions like Agadropant.

    • Exploration of Doja Pant for migraine treatment
    • Definitions and implications of episodic migraines
    • Overview of Agadropant study results and effectiveness


    Thanks for listening! Stay ahead with the latest in clinical medicine, board prep, and earn CME credits.

    Visit www.brilliantcourses.com to learn more and claim credits for this educational activity.

    Stay informed, stay prepared—see you next time!

    続きを読む 一部表示
    2 分
  • Atogepant for TX Refractory Migraine
    2025/02/27

    Send us a text

    Episodic Migraine Treatment: A Look at Gadopant

    This episode delves into the treatment of episodic migraines with gadopant, especially for those who have failed multiple classes of oral preventive migraine treatments. The discussion includes details about episodic migraines, prior treatments like beta blockers and antidepressants, and a comprehensive study involving 315 participants. The study findings, including the effectiveness and side effects of gadopant compared to a placebo, are also covered.

    00:00 Introduction to Dojopant for Migraine Treatment
    00:15 Understanding Episodic Migraines
    00:22 Prior Treatments for Migraines
    00:38 Study Overview and Methodology
    01:02 Study Population and Results
    01:39 Adverse Effects and Conclusion

    続きを読む 一部表示
    2 分
  • The Silent Risk: Understanding Subclinical Atrial Fibrillation
    2025/02/27

    Send us a text

    The theme underscores the importance of understanding subclinical atrial fibrillation and its implications for patient health management. We discuss the ARTESIA trial, highlighting the comparative effectiveness of apixaban and aspirin in patients with prior strokes. The episode also emphasizes the critical need for accurate blood pressure measurements among older adults, particularly when initiating antihypertensive therapies.

    • Overview of subclinical atrial fibrillation and its detection
    • Insights from the ARTESIA trial regarding apixaban vs. aspirin
    • Analysis of antihypertensive medications and fracture risk
    • Importance of correct blood pressure assessment techniques


    続きを読む 一部表示
    9 分

Brilliant Board Review & CMEに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。